Login to MyKarger

New to MyKarger? Click here to sign up.

Login with Facebook

Forgot your password?

Authors, Editors, Reviewers

For Manuscript Submission, Check or Review Login please go to Submission Websites List.

Submission Websites List

Institutional Login
(Shibboleth or Open Athens)

For the academic login, please select your country in the dropdown list. You will be redirected to verify your credentials.

Original Paper

Open Access Gateway

A Study of Serological Markers of Hepatitis B and C Viruses in Istanbul, Turkey

Erden S.a · Büyüköztürk S.a · Çalangu S.b · Yilmaz G.c · Palanduz S.a · Badur S.c

Author affiliations

Departments of aInternal Medicine, bClinical Infectious Diseases and cMicrobiology, Faculty of Medicine, Istanbul University, Istanbul, Turkey

Corresponding Author

Dr. Sükrü Palanduz

Istanbul University, Istanbul Medical Faculty

Department of Internal Medicine, Division of Medical Genetics

Capa, Istanbul 34093 (Turkey)

Fax +90 212 4111393, E-Mail spalanduz@istanbul.edu.tr

Related Articles for ""

Med Princ Pract 2003;12:184–188

Do you have an account?

Login Information

Contact Information

I have read the Karger Terms and Conditions and agree.


Objective: This study was undertaken to investigate the prevalence of HBsAg, anti-HBs and anti-HCV positivity in Istanbul, Turkey. Subjects and Methods: The frequencies of HBsAg, anti-HBs and anti-HCV positivity were determined in 1,157 randomly selected patients attending the outpatient clinic of Istanbul University Hospital, Istanbul, Turkey, during the years 1998 and 2001. All patients underwent complete physical and various routine laboratory examinations. Results: Of the 1,157 patients, the prevalence of HBsAg, anti-HBs and anti-HCV was 6.6, 28.1 and 2.4%, respectively. It appeared that having dental and surgical procedures formed the risk factors for HBV infection. HBsAg positivity in the health care workers was not different from that of the other professions, but anti-HBs was significantly higher in this group. Conclusions: Our findings indicate that HBV infection occurs more frequently than HCV in Istanbul, and this poses an important health problem in the community.

© 2003 S. Karger AG, Basel


  1. Badur S: Viral Hepatitis in Turkey; in Kilicturgay K (ed): Viral Hepatitis. Istanbul, Nobel Tip Kitapevi, 2001, pp 15–22.
  2. Carpenter AB: Enzyme linked immunoassays; in Rose NR, Macario EC, Folds JD, Lane HC, Nakamura RM (eds): Manual of Clinical Laboratory Immunology. Washington, ASM Press, 1997, pp 20–29.
  3. Nie NH, Hull CM, Jenkins JG, Steinbrennar K, Benta DM: Statistical Package of the Social Sciences, ed 2. New York, McGraw-Hill, 1975.
  4. Uzunalimoglu O, Yurdaydaydin C, Cetinkaya H, Bozkaya H, Colakoglu S, Tankurt E, Sarioglu M, Ozenirler S, Akkiz H, Degertekin H, Okten A: Risk factors for hepatocellular carcinoma in Turkey. Dig Dis Sci 2001;46:1022–1028.
    External Resources
  5. Kuru U, Turan O, Saglam Z, Ceylan Y, Nurluoglu M, Agacfidan A: Prevalence of hepatitis virus infection in pregnant women and their families. Eur J Microbiol Infect Dis 1996;15:248–251.
  6. André F: Hepatitis B epidemiology in Asia, the Middle East and Africa. Vaccine 2000;18(suppl 1):S20–S22.
  7. Sidal M, Unuvar E, Oguz F, Cihan C, Onel D, Badur S: Age-specific seroepidemiology of hepatitis A, B, and E infections among children in Istanbul, Turkey. Eur J Epidemiol 2001;17:141–144.
  8. Degertekin H, Tuzcu A, Yalcin K: Horizontal transmission of HBV infection among students in Turkey. Public Health 2000;114:411–412.
    External Resources
  9. Daw MA, Siala IM, Warfalli MM, Muftah MI: Seroepidemiology of hepatitis B virus markers among hospital health care workers: Analysis of certain potential risk factors. Saudi Med J 2000;21:1157–1160.
  10. Weiss Y, Rabinovitch M, Cahaner Y, Noy D, Siegman-Igra Y: Prevalence of hepatitis B virus markers among hospital personnel in Israel: Correlation with some risk factors. J Hosp Infect 1994;26:211–218.
  11. Al-Sohaibani MO, al-Sheikh EH, al-Ballal SJ, Mirghani MA, Ramia S: Occupational risk of hepatitis B and C infections in medical staff. J Hosp Infect 1995;31:143–147.

Article / Publication Details

First-Page Preview
Abstract of Original Paper

Received: December 15, 2002
Accepted: December 21, 2002
Published online: May 28, 2003
Issue release date: July – September

Number of Print Pages: 5
Number of Figures: 0
Number of Tables: 5

ISSN: 1011-7571 (Print)
eISSN: 1423-0151 (Online)

For additional information: https://www.karger.com/MPP

Copyright / Drug Dosage / Disclaimer

Copyright: All rights reserved. No part of this publication may be translated into other languages, reproduced or utilized in any form or by any means, electronic or mechanical, including photocopying, recording, microcopying, or by any information storage and retrieval system, without permission in writing from the publisher.
Drug Dosage: The authors and the publisher have exerted every effort to ensure that drug selection and dosage set forth in this text are in accord with current recommendations and practice at the time of publication. However, in view of ongoing research, changes in government regulations, and the constant flow of information relating to drug therapy and drug reactions, the reader is urged to check the package insert for each drug for any changes in indications and dosage and for added warnings and precautions. This is particularly important when the recommended agent is a new and/or infrequently employed drug.
Disclaimer: The statements, opinions and data contained in this publication are solely those of the individual authors and contributors and not of the publishers and the editor(s). The appearance of advertisements or/and product references in the publication is not a warranty, endorsement, or approval of the products or services advertised or of their effectiveness, quality or safety. The publisher and the editor(s) disclaim responsibility for any injury to persons or property resulting from any ideas, methods, instructions or products referred to in the content or advertisements.